Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.25.1 (
proteasome
)
28,817
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We have employed cDNA cloning to deduce the complete primary structure of a new subunit, designated p27, of the modulator trimer complex that stimulates the association of the PA700 regulator with the catalytic 20S
proteasome
to form the ATP-dependent active 26S
proteasome
. We found two distinct cDNAs encoding two highly homologous proteins except in the C-terminal region, which are termed tentatively p27-1 and p27-2. The short p27-2 cDNA has a deletion of 65 bp near the 3'-end region of the long p27-1 cDNA, which encodes a large protein with an extended C-terminal region, designated p27-L, whereas the long p27-1 cDNA encodes a small protein named p27-S. The polypeptides of p27-L and p27-S consist of 223 and 209 amino acid residues with calculated molecular masses of 24,852 and 22,764 and isoelectric points of 6.50 and 5.28, respectively. Immunoblot analysis with anti-p27 antibody revealed that p27, together with two other ATPase components, TBP1 and p42, was associated with not only the modulator complex but also significantly with the 26S
proteasome
complex, suggesting that the three are common/sharing subunits in these two complexes. By the fluorescence in situ hybridization method, the p27 (
PSMD9
) gene was mapped to the q24.2-q24.3 band of human chromosome 12. Computer-assisted homology analysis revealed the high sequence similarities of p27-L with a possible counterpart in Caenorhabditis elegans and Saccharomyces cerevisiae whose function is yet unknown, the yeast gene that is here termed
NAS2
(non-ATPase subunit 2). Disruption of
NAS2
had no effect on cell viability, indicating that the subunit is not essential for proliferation of yeast cells.
...
PMID:cDNA cloning and characterization of a human proteasomal modulator subunit, p27 (PSMD9). 965 51
Exposure to carcinogenic alkylating agents, oxidizing agents, and ionizing radiation modulates transcript levels for over one third of Saccharomyces cerevisiae's 6,200 genes. Computational analysis delineates groups of coregulated genes whose upstream regions bear known and novel regulatory sequence motifs. One group of coregulated genes contain a number of DNA excision repair genes (including the MAG1 3-methyladenine DNA glycosylase gene) and a large selection of protein degradation genes. Moreover, transcription of these genes is modulated by the
proteasome
-associated protein
Rpn4
, most likely via its binding to MAG1 upstream repressor sequence 2-like elements, that turn out to be almost identical to the recently identified
proteasome
-associated control element (G. Mannhaupt, R. Schnall, V. Karpov, I. Vetter, and H. Feldmann, FEBS Lett. 450:27-34, 1999). We have identified a large number of genes whose transcription is influenced by Rpn4p.
...
PMID:Regulatory networks revealed by transcriptional profiling of damaged Saccharomyces cerevisiae cells: Rpn4 links base excision repair with proteasomes. 1102 85
Analysis of several Saccharomyces cerevisiae ump mutants with defects in ubiquitin (Ub)-mediated proteolysis yielded insights into the regulation of the polyubiquitin gene UBI4 and of
proteasome
genes. High-molecular weight Ub-protein conjugates accumulated in ump mutants with impaired
proteasome
function with a concomitant decrease in the amount of free Ub. In these mutants, transcriptional induction of UBI4 was depending in part on the transcription factor
Rpn4
. Deletion of UBI4 partially suppressed the growth defects of ump1 mutants, indicating that accumulation of polyubiquitylated proteins is deleterious to cell growth. Transcription of
proteasome
subunit genes was induced in ump mutants affecting the
proteasome
, as well as under conditions that mediate DNA damage or the formation of abnormal proteins. This induction required the transcriptional activator
Rpn4
. Elevated
Rpn4
levels in
proteasome
-deficient mutants or as a response to abnormal proteins were due to increased metabolic stability. Up-regulation of
proteasome
genes in response to DNA damage, in contrast, is shown to operate via induction of RPN4 transcription.
...
PMID:Regulatory mechanisms controlling biogenesis of ubiquitin and the proteasome. 1517 33
The 26S
proteasome
is a complex protease consisting of at least 32 different subunits. Early studies showed that
Rpn4
(also named Son1 and Ufd5) is a transcriptional activator of the Saccharomyces cerevisiae
proteasome
genes, and that
Rpn4
is rapidly degraded by the 26S
proteasome
. These observations suggested that in vivo
proteasome
abundance may be regulated by an
Rpn4
-dependent feedback circuit. Here, we present direct evidence to support the
Rpn4
-
proteasome
feedback model. We show that
proteasome
expression is increased when
proteasome
activity is impaired, and that this increase is
Rpn4
-dependent. Moreover, we demonstrate that expression of a stable form of
Rpn4
leads to elevation of
proteasome
expression. Our data also reveal that the
Rpn4
-
proteasome
feedback circuit is critical for cell growth when
proteasome
activity is compromised, and plays an important role in response to DNA damage. This study provides important insights into the mechanism underlying
proteasome
homeostasis.
...
PMID:Homeostatic regulation of the proteasome via an Rpn4-dependent feedback circuit. 1535 14
The homeostatic abundance of the
proteasome
in Saccharomyces cerevisiae is controlled by a feedback circuit in which transcriptional activator
Rpn4
up-regulates the
proteasome
genes and is destroyed by the assembled, active
proteasome
. Remarkably, the degradation of
Rpn4
can be mediated by two independent pathways. One pathway is independent of ubiquitin, whereas the other involves ubiquitination on internal lysines. In the present study, we investigated the mechanism underlying the ubiquitin-dependent degradation of
Rpn4
. We demonstrated, through in vivo and in vitro assays, that
Rpn4
is a physiological substrate of the Ubr2 ubiquitin ligase, which was originally identified as a sequence homolog of Ubr1, the E3 component of the N-end rule pathway. The ubiquitin-conjugating enzyme Rad6, which directly interacts with Ubr2, is also required for the ubiquitin-dependent degradation of
Rpn4
. Furthermore, we showed that deletion of UBR2 exhibited a strong synthetic growth defect with a mutation in the Rpt1
proteasome
subunit when
Rpn4
was overexpressed. This study not only identified the ubiquitination apparatus for
Rpn4
but also unveiled the first physiological substrate of Ubr2. The biological significance of Ubr2-mediated degradation of
Rpn4
is also discussed.
...
PMID:Rpn4 is a physiological substrate of the Ubr2 ubiquitin ligase. 1550 24
Lysine selection is a long-standing problem in protein ubiquitination catalyzed by the RING ubiquitin ligases. It is well known that many substrates carry multiple lysines that can be ubiquitinated. However, it has seldom been addressed whether one lysine is preferred for ubiquitin conjugation when all other lysines exist. Here we studied the mechanism underlying ubiquitin-dependent degradation of
Rpn4
, a transcription activator of the Saccharomyces cerevisiae
proteasome
genes. We found that the ubiquitin-dependent degradation of
Rpn4
can be mediated by six different lysines. Interestingly, we showed through in vivo and in vitro assays that lysine 187 is selected for ubiquitination when all other lysines are available. To the best of our knowledge, this is the first demonstration of a preferential ubiquitination site chosen from a group of lysines susceptible for ubiquitination. We further demonstrated that lysine 187 and a proximal acidic domain constitute a portable degradation signal. The implications of our data are discussed.
...
PMID:Identification of the preferential ubiquitination site and ubiquitin-dependent degradation signal of Rpn4. 1649 66
Heat shock transcription factor (HSF) mediates the transcriptional response of eukaryotic cells to heat, infection and inflammation, pharmacological agents, and other stresses. Although genes encoding heat shock proteins (HSPs) are the best characterized targets of HSF, recent genome-wide localization of Saccharomyces cerevisiae HSF revealed novel HSF targets involved in a wide range of cellular functions. One such target, the RPN4 gene, encodes a transcription factor that directly activates expression of a number of genes encoding
proteasome
subunits. Here we demonstrate that HSF co-ordinates a feed-forward gene regulatory circuit for RPN4 activation. We show that HSF activates expression of PDR3, encoding a multidrug resistance (MDR) transcription factor that also directly activates RPN4 gene expression. We demonstrate that the HSF binding site (HSE) in the RPN4 promoter is primarily responsible for heat- or methyl methanesulphonate induction of RPN4, with a minor contribution of Pdr3 binding sites (PDREs), while a Yap1 binding site (YRE) is responsible for RPN4 induction in response to oxidative stress. Furthermore, heat-induced expression of
Rpn4
protein leads to expression of
Rpn4
targets at later stages of heat stress, providing a temporal controlling mechanism for
proteasome
synthesis upon stress conditions that could result in irreversibly damaged proteins. In addition, the overlapping transcriptional regulatory networks involving HSF, Yap1 and Pdr3 suggest a close linkage between stress responses and pleiotropic drug resistance.
...
PMID:A stress regulatory network for co-ordinated activation of proteasome expression mediated by yeast heat shock transcription factor. 1655 35
Alpha-synuclein containing cellular inclusions are a hallmark of Parkinson Disease, Lewy Body Dementia, and Multiple System Atrophy. A genome wide expression screen was performed in C. elegans overexpressing both wild-type and A53T human alpha-synuclein. 433 genes were up- and 67 genes down-regulated by statistical and fold change (> or <2) criteria. Gene ontology (GO) categories within the regulated gene lists indicated over-representation of development and reproduction, mitochondria, catalytic activity, and histone groups. Seven genes (pdr-1, ubc-7, pas-5, pas-7, pbs-4, RPT2,
PSMD9
) with function in the ubiquitin-
proteasome
system and 35 mitochondrial function genes were up-regulated. Nine genes that form histones H1, H2B, and H4 were down-regulated. These results demonstrate the effects of alpha-synuclein on
proteasome
and mitochondrial complex gene expression and provide further support for the role of these complexes in mediating neurotoxicity. The results also indicate an effect on nuclear protein genes that suggests a potential new avenue for investigation.
...
PMID:Identification of gene expression changes in transgenic C. elegans overexpressing human alpha-synuclein. 1662 60
Proteasomes have been shown to be involved in the regulation of melanin biosynthesis in melanoma cells. Here we report on the correlation between
proteasome
subunits and Tyrosinase (Tyr) activity in different cell phenotypes, and thereby regulation of melanin biosynthesis in B16F10 mouse melanoma cells. Our results indicated that the quantity of
proteasome subunit p27
is higher and that of the enzyme Tyr and its activity are lower in amelanotic melanoma cells, while the reverse is true in melanotic melanoma cells. Proteasome subunit p27, compared to another subunit p31, shows increased co-localization with Tyr and Tyrosinase related protein 1 (Trp1) in amelanotic cells to a greater extent than that in melanotic cells. On exposure to cycloheximide, increased Tyr degradation was seen in amelanotic cells, as indicated by increased co-localization of p27 and Tyr. Further, exposure of amelanotic melanoma cells with
proteasome
-specific inhibitor MG132 resulted in an increased Tyr activity, increased levels of Tyr and Trp1, leading to increased melanin synthesis. These results therefore suggest that proteasomes, particularly p27 subunit, are directly involved in the regulation of melanin biosynthesis in mouse melanoma cells.
...
PMID:Increased level of p27 subunit of proteasomes and its co-localization with tyrosinase in amelanotic melanoma cells indicate its direct role in the regulation of melanin biosynthesis. 1687 86
Multiple genome-wide scans in different populations have linked the chromosome 12q24 region, known as NIDDM2 (non-insulin-dependent-diabetes, locus 2), to type 2 diabetes. Within NIDDM2 we examined the
PSMD9
(
proteasome
modulator 9/Bridge-1) gene that encodes a PDZ-domain transcriptional coactivator of insulin production. Our goal was to identify a potential contribution of the
PSMD9
gene to type 2 diabetes in Italians. We directly sequenced the entire gene
PSMD9
in Italian type 2 diabetes patients (n = 237) and controls subjects (n = 215) and performed an association study with the identified gene variants. We found five single nucleotide polymorphisms (SNPs), A17V, IVS1+nt29, IVS3+nt460, IVS3+nt437, and E197G, which are not associated with disease in our case-control study. Furthermore, we identified two
PSMD9
gene variants in type 2 diabetes patients, which produced nonconservative amino acid substitutions S143G and N166S within the PDZ domain and two other gene variants. Three out of four of these variants are absent from the control subjects screened. We propose that the three
PSMD9
gene variants (S143G, N166S and G > A at IVS3+nt102), absent in control subjects, contribute rarely to late-onset type 2 diabetes in Italians. In fact, the frequency rate of such variants in unrelated cases equals 0.016. We may not exclude that
PSMD9
gene variants may contribute, either commonly or rarely, to an increased risk of type 2 diabetes in other populations.
...
PMID:PSMD9 gene variants within NIDDM2 may rarely contribute to type 2 diabetes. 1751 68
1
2
3
4
5
6
Next >>